EMAIL THIS PAGE TO A FRIEND

Epigenetics

Conserved DNA methylation patterns in healthy blood cells and extensive changes in leukemia measured by a new quantitative technique.


PMID 23075513

Abstract

Genome wide analysis of DNA methylation provides important information in a variety of diseases, including cancer. Here, we describe a simple method, Digital Restriction Enzyme Analysis of Methylation (DREAM), based on next generation sequencing analysis of methylation-specific signatures created by sequential digestion of genomic DNA with SmaI and XmaI enzymes. DREAM provides information on 150,000 unique CpG sites, of which 39,000 are in CpG islands and 30,000 are at transcription start sites of 13,000 RefSeq genes. We analyzed DNA methylation in healthy white blood cells and found methylation patterns to be remarkably uniform. Inter individual differences > 30% were observed only at 227 of 28,331 (0.8%) of autosomal CpG sites. Similarly, > 30% differences were observed at only 59 sites when we comparing the cord and adult blood. These conserved methylation patterns contrasted with extensive changes affecting 18-40% of CpG sites in a patient with acute myeloid leukemia and in two leukemia cell lines. The method is cost effective, quantitative (r ( 2) = 0.93 when compared with bisulfite pyrosequencing) and reproducible (r ( 2) = 0.997). Using 100-fold coverage, DREAM can detect differences in methylation greater than 10% or 30% with a false positive rate below 0.05 or 0.001, respectively. DREAM can be useful in quantifying epigenetic effects of environment and nutrition, correlating developmental epigenetic variation with phenotypes, understanding epigenetics of cancer and chronic diseases, measuring the effects of drugs on DNA methylation or deriving new biological insights into mammalian genomes.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

R6142 Acc I from Acinetobacter calcoaceticus, Restriction Enzyme
R6885 Alu I from Arthrobacter luteus, Restriction Enzyme
R8631
Bcl I from Bacillus caldolyticus, Restriction Enzyme
R6377
Bgl II from Bacillus licheniformis, Restriction Enzyme
R3131
Bln I from Brevibacterium linens, buffered aqueous glycerol solution
R3635
Bsm I from Bacillus stearothermophilus NUB 36, Restriction Enzyme
R4253 BstE II from Bacillus stearothermophilus ET, Restriction Enzyme
R1761
Cfo I from Clostridium formicoaceticum, Restriction Enzyme
R7763
Cla I from Caryophanon latum L, Restriction Enzyme
R4256
Dde I from Desulfovibrio desulfuricans strain Norway, Restriction Enzyme
R4381
Dra I from Deinococcus radiophilus, Restriction Enzyme
R3884 EclX I from Enterobacter cloacae 590, Restriction Enzyme
R6265
EcoR I from Escherichia coli BS5, Restriction Enzyme
R2756
EcoR V from Escherichia coli, buffered aqueous glycerol solution
R5628 Hae III from Haemophilus aegyptius, Restriction Enzyme
R1632
Mva I from Micrococcus varians Rfl 19, Restriction Enzyme
R8761 Nco I from Nocardia corallina, Restriction Enzyme
R5634
Nhe I from Neisseria mucosa heidelbergensis, Restriction Enzyme
R8506
Not I from Nocardia otidiscaviarum, Restriction Enzyme
R5884 Nsi I from Neisseria sicca, Restriction Enzyme
R7023
Pst I from Providencia stuartii, Restriction Enzyme
R1508
Pvu I from Proteus vulgaris, Restriction Enzyme
R2631
Pvu II from Proteus vulgaris, Restriction Enzyme
R4756 Rsa I from Rhodopseudomonas sphaeroides, Restriction Enzyme
R0754 Sal I from Streptomyces albus G, Restriction Enzyme
R8256
Sfi I from Streptomyces fimbriatus, Restriction Enzyme
R7135 Sph I from Streptomyces phaeochromogenes, Restriction Enzyme
R7260
Xba I from Xanthomonas badrii, Restriction Enzyme
R6379
Xho I from Xanthomonas holcicola, Restriction Enzyme
R1259 Afl III from Anabaena flos-aquae, buffered aqueous glycerol solution